Video Experimental Relacionado
Updated: Jul 19, 2026
08:35
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Efecto del péptido natriurético auricular en la actividad simpática muscular y su control reflejo en la insuficiencia
B L Abramson1, S Ando, C F Notarius
1Divisions of Cardiology, the Toronto Hospital and Mount Sinai Hospital, and the Centre for Cardiovascular Research, University of Toronto.
Circulation
|April 13, 1999
Resumen
El péptido natriurético auricular (ANP) inhibe la actividad del nervio simpático muscular (MSNA) en pacientes con insuficiencia cardíaca, incluso durante la presión negativa corporal inferior (LBNP). Este efecto simpatoinhibidor es evidente cuando las presiones auriculares disminuyen sin afectar la presión arterial sistémica.
Área de la Ciencia:
- Fisiología cardiovascular fisiología cardiovascular.
- La neuroendocrinología en neuroendocrinología.
- Insuficiencia cardíaca Fisiopatología Fisiopatología
Sus antecedentes:
- La insuficiencia cardíaca se asocia con una actividad alterada del sistema nervioso simpático.
- El péptido natriurético auricular (ANP) es una hormona con conocidos efectos vasodilatadores y natriuréticos.
- El efecto de la ANP en la actividad del nervio simpático en la insuficiencia cardíaca no se comprende completamente.
Objetivo del estudio:
- Para investigar el efecto simpatoinhibidor de la ANP en pacientes con insuficiencia cardíaca.
- Para determinar si la ANP modula la actividad del nervio simpático muscular (MSNA) en reposo y durante la presión negativa de la parte inferior del cuerpo (LBNP).
Principales métodos:
- Quince hombres con cardiomiopatía dilatada se sometieron a una infusión intravenosa de ANP y nitroglicerina (NTG) como control.
- Se monitorearon los parámetros hemodinámicos, incluida la presión arterial (BP), la presión venosa central (CVP) y la frecuencia cardíaca (HR).
- La actividad muscular del nervio simpático (MSNA) se registró en reposo y durante el LBNP (-6 y -12 mm Hg).
Principales resultados:
- Tanto la ANP como la NTG redujeron la CVP y la BP diastólica de manera similar.
- El MSNA en reposo no aumentó con ninguna de las dos infusiones.
- LBNP indujo reducciones en CVP y BP, con efectos similares durante ANP y NTG.
- MSNA fue significativamente menor durante la infusión de ANP, tanto en reposo como durante LBNP.
- El LBNP no hipotético aumentó el MSNA durante NTG pero no durante ANP.
Conclusiones:
- La ANP ejerce una acción simpatoinhibidora en pacientes con insuficiencia cardíaca.
- Este efecto es más evidente cuando la ANP reduce la presión auricular sin alterar la presión arterial sistémica.
- La ANP puede desempeñar un papel en la modulación de la hiperactividad simpática en la insuficiencia cardíaca.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:17Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...